Drug Approval | October 30, 2025
Granules India’s facility secures FDA EIR with 'VAI’
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection conducted in June 2025
Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plants by volume
USFDA inspection at Emcure Pharmaceuticals API facility
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
The National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for IOL Chemicals and Pharmaceuticals Limited's products.
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
